Latest filing published 14 Aug 2020 for SI-BONE, Inc., €19.5M.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Skyline Venture Partners V LP has filed trades across 5 companies (mainly through SEC (Form 4)), most often in SI-BONE, Inc., Collegium Pharmaceutical, Inc and Dicerna Pharmaceuticals Inc. In total, 28 filings cover trades dated from 14 August 2009 to 27 January 2020.
Both buying and selling appear: 4 purchases worth €11.9M, against 8 sales worth €30.3M. Taken together, the sales exceed the purchases by €18.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2020 alone, the filings show no purchases and 1 sale.
Half of the purchases are above €3.0M and half below.
On 14 August 2020 came the latest disclosure, an open-market sale for €19.5M in SI-BONE, Inc. The last insider purchase was made public on 19 October 2018, 2,926 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 28 declarations